Groupe Athena, Inc. Announces Revenue Update, Projects $65 Million in Revenues
September 23 2013 - 9:00AM
Marketwired
Groupe Athena, Inc. (OTC PINK: GATA) announced on September 23,
2013 that based on the orders in hand, the company expects to
achieve total revenues of $65 million in the current fiscal. The
company is on track to report revenue of $18 million for the
current quarter, which would reflect a growth 17.5% over the
corresponding quarter of the previous year.
As was previously stated, the Indian pharmaceutical industry is
increasingly focusing on exports to the United States and GATA is
well positioned to help them get their products approved by the FDA
for sales in the US. All of these are potential clients and the
Company believes it has an advantage over competitors due to the
facilities based in India, and their ability to deliver quick
feedback to clients that could result in expedited order
generation. With recent additions to equipment, the company will
continue to take on additional contracts and continue to anticipate
further growth.
About Groupe Athena, Inc.
Groupe Athena Inc. was incorporated in June 2008 and began
operations on July 1 of that year. The company is a research and
testing organization and helps various pharmaceutical and medical
products and devices companies in India and Southeast Asia to get
regulatory approvals and facilitate exports of their products to
the United States. The Company accomplishes this by assisting
clients from concept through development, providing consultation on
regulatory requirements, filings and processes.
The company has a research and marketing facility in India that
currently employs 18 consultants and marketing personnel and is
working towards aggressively expanding its presence in the Indian
pharmaceutical industry. The Company's web address is
www.groupeathena.com
Safe Harbor Statement Certain statements
set forth in this press release constitute "forward-looking
statements." Forward-looking statements include, without
limitation, any statement that may predict, forecast, indicate, or
imply future results, performance or achievements, and may contain
the words "estimate", "project", "intend", "forecast",
"anticipate", "plan", "planning", "expect", "believe", "will
likely", "should", "could", "would", "may" or words or expressions
of similar meaning. Such statements are not guarantees of future
performance and are subject to risks and uncertainties that could
cause the company's actual results and financial position to differ
materially from those included within the forward-looking
statements. Forward-looking statements involve risks and
uncertainties, including those relating to the Company's ability to
grow its business. Actual results may differ materially from the
results predicted and reported results should not be considered as
an indication of future performance. The potential risks and
uncertainties include, among others, the Company's limited
operating history, the limited financial resources, domestic or
global economic conditions -- activities of competitors and the
presence of new or additional competition and conditions of equity
markets.
For more information contact: Paul Cornell Corporate Shareholder
Relations, Inc. Cornellpaul6@gmail.com